SYBX

0.96020.01%
JJ

James J. Collins

Co-Founder & Member of Scientific Advisory Board

Dr. James J. Collins, Ph.D., also known as Jim, serves as Venture Partner of Catalio Capital Management, LP from 2021. Dr. Collins is Technical Advisor of Joule Unlimited, Inc. Dr. Collins is Member of Board of Strategic Advisors of Excel Venture Management. Dr. Collins is Member of Scientific Advisory Board of Danaher Corporation from April 2021. Dr. Collins is Member of Biomedical Advisory Board of LifeWave Ltd. Dr. Collins is Termeer Professor of Medical Engineering and Science at MIT, Institute Member, Broad Institute of MIT and Harvard, Synthetic Biology, Systems Biology. Dr. Collins is Member of Scientific Advisory Board of Epitome Biosystems, Inc. Dr. Collins is Founder and Chairman of Scientific Advisory Board of Corvium, Inc. Dr. Collins is Co-Founder and Member of Scientific Advisory Board of Synlogic, Inc. Dr. Collins is Founder of Spexis AG. Dr. Collins is Member of Scientific Advisory Board of Aquinnah Pharmaceuticals, Inc. Dr. Collins is Member of Editorial Advisory Board of Xconomy, Inc. Dr. Collins is Member of Scientific Advisory Board of Asimov, Inc. from January 11, 2019. Dr. Collins is Co-Chairman of Scientific Advisory Board of Engine Biosciences Pte. Ltd. Dr. Collins is Scientific Co-Founder, Chairperson of Scientific Advisory Board and Independent Director of Senti Biosciences Holdings, Inc. Dr. Collins is Co-Founder and Director of Sherlock Biosciences, Inc. from 2022. Dr. Collins is Member of Scientific Advisory Board of Shape Therapeutics Inc. Dr. Collins is Co-Founder and Director of Cellarity, Inc. Dr. Collins is Founder of VULCAN BIOLOGICS, INC. Dr. Collins is Independent Director of Orion Biotech Opportunities Corp. from May 12, 2021. Dr. Collins is Chairman of Scientific Advisory Board of Integrated Biosciences, Inc. Dr. Collins is Member of Scientific Advisory Board of Montai Health, Inc. from 2024. Dr. Collins is Scientific Advisory Board Member of Empress Therapeutics, Inc. from January 2024. Dr. Collins was Co-Chair of Scientific Advisory Board of GNS Healthcare, Inc. from April 2008. Dr. Collins was Member of Scientific Advisory Board of Agilis Biotherapeutics, LLC from March 05, 2014. Dr. Collins was Advisor of PureTech Health plc from November 30, 2015. Dr. Collins was Independent Director of Fulcrum Therapeutics, Inc. from January 2017 to November 12, 2024. Dr. Collins was Adjunct Partner Board of IndieBio from September 2019. Dr. Collins was Member of Scientific Advisory Board of Seres Therapeutics, Inc. Dr. Collins was Member of Scientific Advisory Board of Codon Devices, Inc. Dr. Collins has a Bachelor of Science in Physics from College of the Holy Cross in 1987 and a Doctorate in Medical Engineering from University of Oxford in 1990.

Positions